Elsie Cheang
Lawyers

Filters
Aligos Therapeutics $83.6 million follow-on offering
We advised the underwriters on the stock offering
Theravance Biopharma $100.5 million follow-on offering
We advised the underwriters on the equity offering
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing